-
National centralized insulin collection starts today in Guangxi
Time of Update: 2023-02-20
(Reporter Luo Qi correspondent Long Yixin Jiang Yanfei) Original title: The national centralized procurement of insulin will be launched in Guangxi today, with an average price reduction of 48% and a maximum price reduction of 73%The reporter learned from the Autonomous Region Medical Insurance Bureau that from May 30, the medical and health institutions in our region will uniformly implement the results of the sixth batch of nationally organized centralized drug procurement (special insulin) results .
-
National medical insurance negotiations officially launched, a number of tumors, rare disease new drugs and other blockbuster products participated in the "soul bargaining
Time of Update: 2023-02-03
js?cdnversion='+~(-new Date()/36e5)]; The National Health Insurance Administration previously announced the "List of Declared Drugs Approved for Formal Review for the Adjustment of the National Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance Drug Catalogue in 2022", with a total of 343 drugs officially passing the formal review.
-
Rarely, Legionella infection causes atrioventricular block| case sharing
Time of Update: 2023-02-01
(Figure 1 ECG)(Figure 2 Chest X-ray)Because the patient's D-dimer was too high, pulmonary embolism was suspected, and pulmonary angiography CT results excluded it, confirming consolidation in the upper lobe of the left lung, suggesting infection, and a mild effusion in the right chamber (figure 3).
-
Video: Inhalation-Induction Anesthesia New England Journal of Medicine
Time of Update: 2022-10-13
equipment Equipment necessary for inhalation induction includes anesthetic delivery devices with respiratory circuits; Physiological monitors, including non-invasive blood pressure monitors, pulse oximetry, carbon dioxide and electrocardiogram monitors; Attraction facilities; airway management equipment, such as transparent masks, oral or nasal ventilation tracts, laryngoscopes with handles and blades, supraglottic airway equipment and tracheal catheters; First aid drugs, such as succinylcholine and atropine for intramuscular or intravenous injection; Devices for establishing intravenous access; Anesthetic drugs, including inducing drugs and neuromuscular blockers.
-
Peak circuit turning, willow dark flower bright | a patient with mCRC after multiple progression of the treatment choice
Time of Update: 2022-09-21
*For medical professionals onlyThe third line of advanced CRC uses fruquintinib to seek a first-line life for the patientData show that 25 percent of colorectal cancer (CRC) patients have metastasized
-
Express delivery across the blood-brain barrier
Time of Update: 2022-09-07
▲If you have any business needs, please long press to scan the QR code above, or▎Edited by WuXi AppTec Content TeamDenali Therapeutics today announced new interim results from a Phase 1/2 clinical trial of its investigational enzyme replacement therapy DNL310 in mucopolysaccharidosis type II (MPS II, also known as Hunter syndrome) .
-
Targeted use from September 1, how to use Beijing medical insurance personal account funds
Time of Update: 2022-09-06
However, you can use your social security card to use your personal account (including mutual aid account) for payment, and the shortfall will be made up by the insured in cash .
-
The pace of mergers and acquisitions in the biopharmaceutical industry has accelerated, and domestic pharmaceutical companies have fallen in love with acquiring overseas companies
Time of Update: 2022-08-30
Sihuan Pharmaceutical announced in January that its subsidiary Yaozhong International has acquired the entire equity of Genesis Biosystems in the United States, further expanding the company's medical beauty product pipeline .
-
How are people with rheumatism vaccinated
Time of Update: 2022-08-20
High-dose and adjuvant influenza vaccines are conditionally recommended for elderly patients with rheumatism ≥65 years of age and those aged >18 years and 18 years of age who are receiving immunosuppressive therapy .
-
Chinese Voice: What is the effect of collateral circulation compensation on endovascular treatment of basilar artery occlusion
Time of Update: 2022-03-09
The effect of collateral circulation compensation on endovascular therapy (EVT) for basilar artery occlusion (BAO) is currently unclear .
STUDY INTRODUCTION Eligible participants with a composite collateral score collected in the Endovascular Treatment of Acute Basilar Artery Occlusion Study were included in the study .
-
Preview of the third quarterly report of the API industry
Time of Update: 2021-10-20
Regarding the reasons for the changes in performance, Huahai Pharmaceutical said that during the reporting period, the company’s net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses fell sharply year-on-year, mainly due to the general decline in raw material drug product prices, the decline in the US dollar exchange rate, and product sales.
-
Renfu Class 1 New Drug Propofol Disodium for Injection Approved for Marketing
Time of Update: 2021-06-23
On May 24, the official website of NMPA showed that Renfu’s Class 1 new drug, propofol disodium for injection, was approved for marketing, and the indication was general anesthesia induction .
-
The performance has changed, and the main products have been hit hard...Can Yuheng Pharmaceutical, which has broken arms to survive, can get out of the predicament
Time of Update: 2021-06-16
During the reporting period, affected by the national key medical monitoring catalogue, Yuheng Pharmaceutical's sales revenue of creatine phosphate for injection (Leibton) in 2020 was 12,413,700 yuan, a decrease of 74.
-
Stones from Other Mountains | Experience Sharing of the Latest Approved PK Software (1): Spanish Experience
Time of Update: 2021-05-10
Recently, a web-based medical application-PK-guided hemophilia A management tool (recombinant human coagulation factor VIII dose calculation software for injection, hereinafter referred to as "PK software") has been approved by the National Medical Products Administration (NMPA) Approved, applicable to hemophilia A patients 16 years and older (45kg and above) receiving rAHF-PFM treatment.
-
Improve the mutual aid mechanism of the medical insurance fund to enlarge the protection efficiency
Time of Update: 2021-05-09
From the perspective of "great mutual aid", after adjusting the billing structure of the overall fund and individual accounts, the power of the overall fund can be strengthened, and the scope of the mutual aid of the overall fund can be expanded, which can improve the social mutual aid security level of employee medical insurance.
